TIDMSCPA
RNS Number : 4740G
Scapa Group PLC
23 July 2019
23 July 2019
LEI No. 213800QIPVTK5ES5UU36
Scapa Group plc
('Scapa' or 'the Company')
Result of AGM
Scapa Group plc (AIM: SCPA) is pleased to announce that all
resolutions proposed at its Annual General Meeting held on 23 July
2019 were duly passed by shareholders on a poll. The poll votes on
each resolution proposed are set out below:-
Resolution For Against Withheld
1 To receive the Accounts and Reports
of the Directors and Auditors for the
year ended 31 March 2019 100,106,116 0 76,750
100%* 0.00%*
------------ ----------- ----------
2 To approve the Directors' Remuneration
Report (excluding the Directors' Remuneration
Policy) for the financial year ended
31 March 2019. 85,747,141 14,131,980 303,745
85.85%* 14.15%*
------------ ----------- ----------
3 To approve the Directors' Remuneration
Policy for the financial year ended 31
March 2019. 98,390,796 1,787,365 4,705
98.22%* 1.78%*
------------ ----------- ----------
4 To declare a final dividend of 2.9p
per ordinary share 100,180,981 0 1,885
100%* 0.00%*
------------ ----------- ----------
5 To re-elect Larry Pentz as a Director 98,349,198 864,689 968,979
99.13%* 0.87%*
------------ ----------- ----------
6 To re-elect Heejae Chae as a Director 100,016,778 162,703 3,385
99.84%* 0.16%*
------------ ----------- ----------
7 To re-elect David Blackwood as a Director 99,900,151 279,330 3,385
99.72%* 0.28%*
------------ ----------- ----------
8 To re-elect Pierre Guyot as a Director 99,915,069 264,412 3,385
99.74%* 0.26%*
------------ ----------- ----------
9 To re-elect Brendan McAtamney as a
Director 99,915,069 264,412 3,385
99.74%* 0.26%*
------------ ----------- ----------
10 To elect Oskar Zahn as a Director 99,562,291 618,704 1,871
99.38%* 0.62%*
------------ ----------- ----------
11 To elect Sevan Demirdogen as a Director 100,018,292 162,703 1,871
99.84%* 0.16%*
------------ ----------- ----------
12 To elect Joseph Doherty as a Director 100,018,292 162,703 1,871
99.84%* 0.16%*
------------ ----------- ----------
13 RESOLUTION WITHDRAWN
14 To reappoint Deloitte LLP as auditor
of the Company 99,273,495 607,140 302,231
99.39%* 0.61%*
------------ ----------- ----------
15 To authorise the Directors to fix
the remuneration of the auditor 100,107,256 74,879 731
99.93%* 0.07%*
------------ ----------- ----------
16 That the rules of the Scapa Group
plc 2019 Long Term Incentive Plan are
approved 98,502,321 1,678,685 1,860
98.32%* 1.68%*
------------ ----------- ----------
17 To authorise the Company to make political
donations 98,529,711 1,651,295 1,860
98.35%* 1.65%*
------------ ----------- ----------
18 To authorise the Directors to allot
shares 93,047,128 7,128,878 6,860
92.88%* 7.12%*
------------ ----------- ----------
19 To authorise the Directors to dis-apply
pre-emption rights in relation to the
customary 5% power pursuant to the statement
of principles dis-applying pre-emption
rights 100,174,274 1,361 7,231
100%* 0.00%*
------------ ----------- ----------
20 To authorise the Directors to dis-apply
pre-emption rights in relation to the
additional 5% power to be used in connection
with an acquisition or a specified capital
investment 99,288,893 885,782 8,191
99.12%* 0.88%*
------------ ----------- ----------
21 To authorise the Company to make market
purchases of its own shares 99,867,159 300,401 15,306
99.70%* 0.30%*
------------ ----------- ----------
* as a percentage of votes cast
For further information:
Scapa Group plc:
Wendy Baker
Company Secretary +44 (0) 161 301 7400
Numis Securities Limited:
Mark Lander/Richard Thomas
(Joint Broker/Nominated Adviser) +44 (0) 20 7260 1000
About Scapa Group plc
Scapa Group plc is a diversified Healthcare and Industrial
company focused on bringing best-in-class innovation, design and
manufacturing solutions to its customers.
Healthcare
Scapa Healthcare is the trusted strategic partner of choice for
the world's leading companies in Advanced Wound Care, Consumer
Wellness and Medical Device Fixation. We partner with the top
global MedTech companies to develop and manufacture innovative skin
friendly medical device fixation and topical solutions, from
inception through to market delivery, from our state-of-the-art
facilities.
For further information, please visit
www.scapahealthcare.com
Industrial
Scapa Industrial is a global supplier of bonding solutions and
manufacturer of adhesive-based products which offer meaningful
value in industrial applications due to their lightweight,
easy-to-apply properties. We are recognised for our unparalleled
range of products, including adhesive tapes, films and foams, and
we can engineer custom designs for even the most unique
applications.
For further information, please visit
www.scapaindustrial.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGPGUMWMUPBGAW
(END) Dow Jones Newswires
July 23, 2019 11:39 ET (15:39 GMT)
Grafico Azioni Scapa (LSE:SCPA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Scapa (LSE:SCPA)
Storico
Da Apr 2023 a Apr 2024
